Imamura Tetsuya, Ishizuka Osamu, Yamamoto Tokunori, Gotoh Momokazu, Nishizawa Osamu
Department of Urology, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Low Urin Tract Symptoms. 2010 Apr;2(1):1-10. doi: 10.1111/j.1757-5672.2010.00066.x.
Regenerative medicine offers great hope for lower urinary tract dysfunctions due to irreversibly damaged urinary bladders and urethras. Our aim is the utilization of bone marrow-derived cells to reconstruct smooth muscle layers for the treatments of irreversibly damaged lower urinary tracts. In our mouse model system for urinary bladder regeneration, the majority of smooth muscle layers in about one-third of the bladder are destroyed by brief freezing. Three days after wounding, we implant cultured cells derived from bone marrow. The implanted bone marrow-derived cells survive and differentiate into layered smooth muscle structures that remediate urinary dysfunction. However, bone marrow-derived cells implanted into the intact normal urinary bladders do not exhibit these behaviors. The presence of large pores in the walls of the freeze-injured urinary bladders is likely to be helpful for a high rate of survival of the implanted cells. The pores could also serve as scaffolding for the reconstruction of tissue structures. The surviving host cells upregulate several growth factor mRNAs that, if translated, can promote differentiation of smooth muscle and other cell types. We conclude that the multipotency of the bone marrow-derived cells and the provision of scaffolding and suitable growth factors by the microenvironment enable successful tissue engineering in our model system for urinary bladder regeneration. In this review, we suggest that the development of regenerative medicine needs not only a greater understanding of the requirements for undifferentiated cell proliferation and targeted differentiation, but also further knowledge of each unique microenvironment within recipient tissues.
再生医学为因膀胱和尿道不可逆损伤导致的下尿路功能障碍带来了巨大希望。我们的目标是利用骨髓来源的细胞重建平滑肌层,以治疗不可逆损伤的下尿路。在我们的膀胱再生小鼠模型系统中,约三分之一膀胱的大部分平滑肌层通过短暂冷冻被破坏。损伤三天后,我们植入从骨髓中培养的细胞。植入的骨髓来源细胞存活并分化为分层的平滑肌结构,从而改善排尿功能障碍。然而,植入完整正常膀胱的骨髓来源细胞并未表现出这些行为。冷冻损伤膀胱壁上的大孔隙可能有助于提高植入细胞的存活率。这些孔隙还可作为组织结构重建的支架。存活的宿主细胞上调了几种生长因子mRNA,如果这些mRNA被翻译,可促进平滑肌和其他细胞类型的分化。我们得出结论,在我们的膀胱再生模型系统中,骨髓来源细胞的多能性以及微环境提供的支架和合适的生长因子促成了成功的组织工程。在这篇综述中,我们认为再生医学的发展不仅需要更深入了解未分化细胞增殖和定向分化的要求,还需要进一步了解受体组织内每个独特的微环境。